ABBV vs WAT
By Alex · Tickerpine
AbbVie Inc. vs Waters Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | WAT |
|---|---|---|
| Price | $295.03 | $460.25 |
| Market cap | $521.50B | $90.45B |
| P/E ratio | 50.7 | 192.6 |
| ROE | — | 1.12% |
| Profit margin | 15.67% | 1.76% |
| Revenue growth | 10.30% | 120.90% |
| Dividend yield | 2.35% | 0.00% |
| Beta | 0.19 | 1.15 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs WAT in plain English
- ABBV is the bigger company — about 5.8× the market cap of WAT.
- ABBV is cheaper on earnings (P/E 50.7 vs 192.6).
- WAT is growing revenue faster (121% vs 10%).
- ABBV pays a dividend (2.35%) while the other effectively doesn't.
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
WAT return calculator
See what $1,000 in Waters Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.